Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease
Recent Patents on Inflammation & Allergy Drug Discovery · 2007
DOI: 10.2174/187221307779815093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on Inflammation & Allergy Drug Discovery, 2007. Verfasst von Jean-Marie Reimund und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Nutrition, Caen University Hospital (Hôpital Côte de Nacre), Caen, France. reimund-jm@chu-caen.fr. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology and Nutrition, Caen University Hospital (Hôpital Côte de Nacre), Caen, France. reimund-jm@chu-caen.fr
Zitieren
APA
Reimund, J. M., Ratajczyk, J., Sola, B., Justum, A. M., & Muller, C. D. (2007). Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease. Recent Patents on Inflammation & Allergy Drug Discovery. https://doi.org/10.2174/187221307779815093
Vancouver
Reimund JM, Ratajczyk J, Sola B, Justum AM, Muller CD. Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease. Recent Patents on Inflammation & Allergy Drug Discovery. 2007. doi:10.2174/187221307779815093
BibTeX
@article{Reimund2007,
author = {Reimund, Jean-Marie and Ratajczyk, Julia and Sola, Brigitte and Justum, Anne-Marie and Muller, Christian D},
title = {Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease},
journal = {Recent Patents on Inflammation & Allergy Drug Discovery},
year = {2007},
doi = {10.2174/187221307779815093}
}
EUVIMED